Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma

NCT01818752 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

955

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Carfilzomib
DRUG: Bortezomib
DRUG: Melphalan
DRUG: Prednisone

Sponsor

Amgen